Combination therapy for treatment of cancer comprising anti-pd-l1 and anti-cd73 antibodies
US-2025340648-A1 · Nov 6, 2025 · US
Dovedi Simon is listed as an inventor on 15 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Dovedi Simon |
| Total patents | 15 |
| First publication | Feb 25, 2016 |
| Latest publication | Nov 6, 2025 |
Publications ranked by popularity score, then publication date.
US-2025340648-A1 · Nov 6, 2025 · US
US-2025249093-A1 · Aug 7, 2025 · US
US-2025115678-A1 · Apr 10, 2025 · US
US-2025074986-A1 · Mar 6, 2025 · US
US-2025059295-A1 · Feb 20, 2025 · US
US-RE49908-E · Apr 9, 2024 · US
US-2022251204-A1 · Aug 11, 2022 · US
US-11279759-B2 · Mar 22, 2022 · US
US-2022073622-A1 · Mar 10, 2022 · US
US-2020172622-A1 · Jun 4, 2020 · US
Latest publications not already listed above.
US-10457732-B2 · Oct 29, 2019 · US
US-2019241659-A1 · Aug 8, 2019 · US
US-2019192655-A1 · Jun 27, 2019 · US
US-10092645-B2 · Oct 9, 2018 · US
US-2016051672-A1 · Feb 25, 2016 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Medimmune Llc | 8 |
| Medimmune Ltd | 4 |
| Astrazeneca Ab | 3 |
| Univ Manchester | 2 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K2039/505 | 15 |
| A61P35/00 | 14 |
| C07K2317/73 | 12 |
| C07K16/2827 | 12 |
| A61K39/395 | 11 |